Detalhe da pesquisa
1.
Clinical validation of a ctDNA-Based Assay for Multi-Cancer Detection: An Interim Report from a Vietnamese Longitudinal Prospective Cohort Study of 2795 Participants.
Cancer Invest
; : 1-17, 2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719061
2.
Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A.
J Korean Med Sci
; 28(2): 237-46, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23400519
3.
Immunotherapy using dendritic cells against multiple myeloma: how to improve?
Clin Dev Immunol
; 2012: 397648, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22481968
4.
Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
Ann Hematol
; 90(12): 1419-26, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21465188
5.
Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
Ann Hematol
; 88(11): 1113-23, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19277657
6.
Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells.
Oncotarget
; 8(28): 46047-46056, 2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28512265
7.
Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma.
Exp Hematol
; 46: 48-55, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27889516
8.
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.
Oncotarget
; 8(16): 27252-27262, 2017 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28460478
9.
Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells.
J Immunol Res
; 2015: 706379, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26221615
10.
Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma.
J Immunother
; 38(8): 330-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26325377
11.
Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic.
Chonnam Med J
; 51(1): 1-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25914874
12.
Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro.
Exp Hematol
; 42(4): 274-81, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24407159
13.
Cellular immunotherapy using dendritic cells against multiple myeloma.
Korean J Hematol
; 47(1): 17-27, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22479274
14.
In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.
Exp Mol Med
; 44(1): 60-7, 2012 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22089087
15.
Identification of novel HLA-A*0201-restricted epitopes from anterior gradient-2 as a tumor-associated antigen against colorectal cancer.
Cell Mol Immunol
; 9(2): 175-83, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22231555
16.
Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.
Cell Mol Immunol
; 9(1): 45-53, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21822297
17.
Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists.
Cell Mol Immunol
; 8(4): 341-7, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21423200
18.
Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma.
Leuk Res
; 35(9): 1241-7, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21612823
19.
Optimization and limitation of calcium ionophore to generate DCs from acute myeloid leukemic cells.
Cancer Res Treat
; 39(4): 175-80, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19746185